Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...

Researchers found that methanolic extracts from sweet potato leaves and stems significantly inhibit breast and lung cancer ...

Multiple pathways of non-apoptotic cell death have recently been described, namely autophagic cell death, necroptosis and poly (ADP–ribose) polymerase-1 (PARP1)-mediated cell death. Emerging ...

Immunogenic cell death (ICD) is a rapidly growing research area representing one of the emerging therapeutic strategies of cancer immunotherapy. ICD is an umbrella term covering several cell death ...

The portable incubator allows worry-free mobility between labs while safeguarding the integrity of sensitive biological ...

In localized non-small cell lung cancer (NSCLC), a tumor's ability to use carbon from glucose to feed the tricarboxylic acid ...

Moreover, erianin-induced cell death could be rescue by co-treatment with ROS inhibitor N-acetyl-l-cysteine ... The CCK-8 (Cat: MA0218) (meilunbio, Dalian, China) proliferation assay was used to ...

He noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second paper, it usually shows that [the test] fails for earl ...

The assay is designed to detect endometrial cancer patients who can benefit from the ... and polo-like kinase 1 (PLK1), driving pro-apoptotic cell death. The FDA’s breakthrough device designation is ...

coli bacteria produces an enzyme which breaks the contents of their cells down into nutrients after death. The dead bacteria are therefore offering a banquet of nutrients to the cells that were ...

Developed using the Acrivon Predictive Precision Proteomics (AP3) platform, the multiplex immunofluorescence assay is currently ... driving pro-apoptotic cell death. The FDA's breakthrough device ...